La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Pulmatrix Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Peter Ludlum
Amministratore delegato
US$510.2k
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | less than a year |
Proprietà del CEO | n/a |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | 4.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
There Is A Reason Pulmatrix, Inc.'s (NASDAQ:PULM) Price Is Undemanding
Aug 02Pulmatrix doses first subjects in phase 1 trial of acute migraine treatment PUR3100
Jul 12Is Pulmatrix (NASDAQ:PULM) In A Good Position To Invest In Growth?
Feb 22Is Pulmatrix (NASDAQ:PULM) In A Good Position To Deliver On Growth Plans?
Oct 29Pulmatrix, Inc.'s (NASDAQ:PULM) Sole Analyst Just Made A Massive Upgrade To Their Forecasts
Aug 16Earnings Beat: Pulmatrix, Inc. (NASDAQ:PULM) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 14We're Not Very Worried About Pulmatrix's (NASDAQ:PULM) Cash Burn Rate
May 27We're Not Very Worried About Pulmatrix's (NASDAQ:PULM) Cash Burn Rate
Feb 11AMMINISTRATORE DELEGATO
Peter Ludlum (69 yo)
less than a year
Mandato
US$510,224
Compensazione
Mr. Peter B. Ludlum, CMA, MBA, served as Interim Chief Financial Officer and Principal accounting & financial officer at Pulmatrix, Inc. since April 18, 2022 until July 20, 2024 and also serves as its Inte...
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Independent Chairman | 9.3yrs | US$92.97k | 0% $ 0 | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 4.3yrs | US$50.56k | 0% $ 0 | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 4.9yrs | US$59.56k | 0.00068% $ 52.4 | |
Independent Director | 4yrs | US$58.06k | 0% $ 0 | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Pulmazole Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Chair of PUR1900 & PUR1800 Clinical Advisory Board | no data | Nessun dato | Nessun dato | |
Chair of PUR3100 (DHE) Clinical Advisory Board | no data | Nessun dato | Nessun dato |
4.6yrs
Durata media
55yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PULM sono considerati esperti (durata media dell'incarico 4.5 anni).